000 01307 a2200313 4500
005 20250518000947.0
264 0 _c20191125
008 201911s 0 0 eng d
022 _a1477-092X
024 7 _a10.1177/1078155218800371
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBektas, Mert
245 0 0 _aA severe case of bevacizumab-induced thrombotic microangiopathy.
_h[electronic resource]
260 _bJournal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
_cOct 2019
300 _a1754-1757 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article
650 0 4 _aAngiogenesis Inhibitors
_xadministration & dosage
650 0 4 _aBevacizumab
_xadministration & dosage
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMiddle Aged
650 0 4 _aThrombotic Microangiopathies
_xchemically induced
700 1 _aSamancı, Nilay S
700 1 _aCokgezer, Simay
700 1 _aKeskin, Dilek
700 1 _aDemirelli, Fuat H
773 0 _tJournal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
_gvol. 25
_gno. 7
_gp. 1754-1757
856 4 0 _uhttps://doi.org/10.1177/1078155218800371
_zAvailable from publisher's website
999 _c28872981
_d28872981